Pharmacokinetics and antiviral activity of a novel isonucleoside, BMS-181165, against simian varicella virus infection in African green monkeys
- 30 April 1994
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 23 (3-4) , 219-224
- https://doi.org/10.1016/0166-3542(94)90019-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Synthesis and antiviral activity of novel isonucleoside analogsJournal of Medicinal Chemistry, 1993
- Oral Bioavailability and Anti-Simian Varicella Virus Efficacy of 1- -D-Arabinofuranosyl-E-5-(2-Bromovinyl)Uracil (BV-araU) in MonkeysThe Journal of Infectious Diseases, 1992
- A Controlled Trial of Acyclovir for Chickenpox in Normal ChildrenNew England Journal of Medicine, 1991
- Treatment of Varicella–Zoster Virus Infection in Severely Immunocompromised PatientsNew England Journal of Medicine, 1986
- Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeysAntimicrobial Agents and Chemotherapy, 1986
- Investigation of antiviral activity of 1-β-d-arabinofuranosylthymine (ara-T) and 1-β-d-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-ara-U) in monkeys infected with simian varicella virusAntiviral Research, 1984
- Acyclovir treatment of experimental simian varicella infection of monkeysAntimicrobial Agents and Chemotherapy, 1981